Tenaya Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -2,084 | |||
EBITDA | -21,199 | -24,877 | -22,563 | -24,610 |
EBIT | -23,283 | -27,538 | -24,652 | -26,711 |
Net Income | -23,283 | -26,864 | -23,836 | -25,634 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -15,755 | -23,495 | -18,592 | -20,020 |
Cash | 62,671 | 53,772 | 4,323 | 8,231 |
Basic Shares | 162,791 | 109,869 | 86,406 | 86,162 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -8,687 | -8,713 | -4,025 | |
EBITDA | -102,661 | -122,506 | -119,154 | -69,845 |
EBIT | -111,129 | -131,193 | -125,621 | -72,806 |
Net Income | -111,129 | -124,084 | -123,663 | -69,652 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | 56,995 | -90,406 | ||
Free Cash Flow | -91,526 | -103,311 | -125,054 | -85,933 |
Cash | 4,323 | 45,681 | 95,272 | 38,129 |
Basic Shares | 84,822 | 73,786 | 44,823 | 41,291 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.14 |
2025-03-31 | -$0.24 |
2024-12-31 | -$0.28 |
